| Ytd | 24.95% | |
| 1y | 13.90% |
| Open | 12.75 | Prev Close | 12.81 | Low | 12.63 | High | 12.86 | Mkt Cap | 442.22M |
| Vol | 12.55K | Avg Vol | 476.15K | EPS | 0.01 | P/E | 1281.00 | Forward P/E | -35.75 |
| Beta | 0.49 | Short Ratio | 5.26 | Inst. Own | 38.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 11.88 | 200-d Avg | 10.42 | 1yr Est | 21.33 |
DCTH News
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”)
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
On May 22, 2026, Delcath Systems Inc (DCTH) shares fell 3.8%, bringing the current price to $11.02.
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”)
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
Delcath Systems, Inc. (DCTH) Q1 2026 Earnings Call Transcript
Delcath Systems, Inc. (DCTH) came out with a quarterly loss of $0.03 per share versus the Zacks Cons
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology
Delcath Systems (NASDAQ: DCTH - Get Free Report) and ADB International Group (OTCMKTS:EQUR - Get Fre
Delcath Systems, Inc. (NASDAQ: DCTH - Get Free Report) has earned an average recommendation of "Mode
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”
Delcath Systems, Inc.'s revenue remains under pressure due to weak patient starts in the third quart
Delcath Systems (NASDAQ: DCTH) reported record results for 2025 and outlined a commercial and clinic
Delcath Systems, Inc. (DCTH) Q4 2025 Earnings Call Transcript
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”)
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss
During Wednesday's trading, 517 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.